CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression Of Rheumatoid Arthritis
CEL-SCI Corporation (NYSE CVM) and their scientific collaborators announced that the Company’s CEL-2000 vaccine demonstrated that it is able to block the progression of rheumatoid arthritis (RA) in a mouse model…
More: continued here
Filed under: Arthritis on February 26th, 2010
You must be logged in to post a comment.